Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: The Rancho Bernardo Study

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 11-12, 2009, Pages 1137-1149

  Loomba, R ^a   Bettencourt, R ^a   Barrett Connor, E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Medicine

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CORRELATION ANALYSIS; FEMALE; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIVER DISEASES; MALE; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

EID: 70350752461     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04141.x     Document Type: Article

References (38)

1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004 291 : 1238 1245.
2. Banks J, Marmot M, Oldfield Z, Smith JP. Disease and disadvantage in the United States and in England. JAMA 2006 295 : 2037 2045.
3. Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005 352 : 1138 1145.
4. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006 295 : 1549 1555.
5. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood) 2002 21 : 245 253.
6. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008 47 : 1363 1370.
7. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003 98 : 960 967.
8. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007 25 : 883 889.
9. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006 101 : 76 82.
10. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000 132 : 112 117.
11. Ioannou GN, Weiss NS, Boyko EJ, Kahn SE, Lee SP. Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease. Gastroenterology 2005 128 : 627 635.
12. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002 123 : 1705 1725.
13. Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. N Engl J Med 1995 332 : 1245 1250.
14. Jackson R, Beaglehole R. Alcohol consumption guidelines: relative safety vs absolute risks and benefits. Lancet 1995 346 : 716.
15. Hall KE, Proctor DD, Fisher L, Rose S. American gastroenterological association future trends committee report: effects of aging of the population on gastroenterology practice, education, and research. Gastroenterology 2005 129 : 1305 1338.
16. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007 4 : e297.
17. Barrett-Connor E, Suarez L. A community study of alcohol and other factors associated with the distribution of high density lipoprotein cholesterol in older vs. younger men. Am J Epidemiol 1982 115 : 888 893.
18. Barrett-Connor E, Wingard DL, Criqui MH. Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited. JAMA 1989 261 : 2095 2100.
19. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991 265 : 627 631.
20. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002 137 : 1 10.
21. Prati D, Colli A, Conte D, Colombo M. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005 42 : 1460 1461. author reply 1461.
22. Loomba R, Hwang SJ, O'Donnell CJ, et al. Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the framingham heart study. Gastroenterology 2008 134 : 953 959.
23. The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med 1976 5 : 207 215.
24. Lipid Research Clinics Program Manual of Laboratory Operations: Vol 1: Lipid and Lipoprotein Analysis, 2nd edn. Washington, DC : US Government Printing Office, US Dept of Health, Education, and Welfare, 1974. NIH publication No. 75-628. In.
25. Jones BR, Barrett-Connor E, Criqui MH, Holdbrook MJ. A community study of calorie and nutrient intake in drinkers and nondrinkers of alcohol. Am J Clin Nutr 1982 35 : 135 139.
26. Holbrook TL, Barrett-Connor E, Wingard DL. A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990 132 : 902 909.
27. Holbrook TL, Barrett-Connor E. A prospective study of alcohol consumption and bone mineral density. BMJ 1993 306 : 1506 1509.
28. Berenbaum MC. Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol 1977 28 : 1 18.
29. Ruhl CE, Everhart JE. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 2005 3 : 1260 1268.
30. Suzuki A, Angulo P, St Sauver J, Muto A, Okada T, Lindor K. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol 2007 102 : 1912 1919.
31. Lee DH, Ha MH, Christiani DC. Body weight, alcohol consumption and liver enzyme activity - a 4-year follow-up study. Int J Epidemiol 2001 30 : 766 770.
32. Nagata K, Suzuki H, Sakaguchi S. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci 2007 32 : 453 468.
33. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004 34 : 9 19.
34. You M, Crabb DW. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol 2004 287 : G1 6.
35. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004 99 : 1497 1502.
36. Schattenberg JM, Wang Y, Singh R, Rigoli RM, Czaja MJ. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem 2005 280 : 9887 9894.
37. Koteish A, Yang S, Lin H, Huang X, Diehl AM. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J Biol Chem 2002 277 : 13037 13044.
38. Diehl AM. Cytokines and the molecular mechanisms of alcoholic liver disease. Alcohol Clin Exp Res 1999 23 : 1419 1424.